ACD Labs Logo

High Throughput Experimentation Made Easier Than Ever Before

Software for automated planning, execution, and analysis of high throughput experiments

Katalyst D2D is a web-based software application that offers a single interface for high throughput experimentation from Design to Decide.

Delivering comprehensive process development and execution, enabled by live analytical data.

Katalyst D2D enables you to automate manual tasks and eliminates transcription between the multiple systems you are currently using to plan and execute high throughput experiments—array-based chemistry or parallel synthesis.

Katalyst is purpose-built to automate and analyze your entire high throughput experiment workflow in one interface. It helps you design, plan, and execute array-based experiments by integrating with your lab automation—informatics systems and laboratory hardware.

Katalyst also supports high throughput analysis. It will help automatically analyze and assemble all your analytical data, from entire studies, in one place. So, you can comprehensively get from Design to Decide in one application.


Efficient design, planning, execution, and analysis of catalyst screening experiments can present a significant productivity challenge to process chemistry groups. Katalyst D2D provides scientists with a single application interface to effectively identify catalytic conditions for process routes of interest as efficiently as possible.
Read more

See how Katalyst D2D can help streamline the processing and review of analytical data, directly associate analytical results with array design and well-plate location, and reprocess data efficiently.
Watch on Demand

Kevin Arendt of BMS showcases how they are using Katalyst D2D. An introduction to Katalyst D2D for those involved in high throughput (HT)/parallel synthesis, looking to improve automation productivity gains, or considering investments in automation.
Watch on Demand

Join us on a 4-decade journey through HTE. From the 80s and early 90s, to what's happening in pharmaceutical labs today, and what scientists hope for in the future, you'll hear it on Episode 5 of The Analytical Wavelength.
Read more

The pharmaceutical industry has renewed its interest in HTE these last few years. Leaders see it as a way to get medicines to patients faster, but they're also attracted by the sheer quantity of data generated in parallel experiments. How and where should HTE be set up for maximum success? Read this blog for questions that should be considered.
Read more

In this article Ruairi Mackenzie speaks with ACD/Labs' Andrew Anderson about Anderson's unique vantage point into how technology affects the analytical chemistry field. Read on for a discussion of how the day-to-day life of a chemist has been changed by technologies like AI and automation and how budding chemists can get their skillset up to scratch to handle the changing face of analytical science.
Read more